Durect competitorsClear all

Durect's top competitors include Array BioPharma, Amicus Therapeutics, Clinigen Group and Recro Gainesville.
Durect
Durect
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
Array BioPharma
Array BioPharma
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Clinigen Group
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Recro Gainesville
Recro Gainesville
Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
Founding Date
Founding Date
N/A
Founding Date
1998
Founding Date
2002
Founding Date
2010
Founding Date
2006
Type
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cupertino, US HQ
Locations
Boulder, US HQ
Cambridge, US
Chicago, US
Detroit, US
Houston, US
Miami, US
Morrisville, US
see more
Locations
Cranbury Township, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin 15, IE
Milano, IT
see more
Locations
Burton upon Trent, GB HQ
Warriewood, AU
Chuo City, JP
Singapore, SG
Pretoria, ZA
Hobson, GB
London, GB
see more
Locations
Malvern, US HQ
Gainesville, US
Gainesville, US
Employees
Employees
902% increase
Employees
29843% increase
Employees
58415% increase
Employees
1,13342% increase
Employees
21316% decrease
Valuation ($)
Valuation ($)
467.3 m
Valuation ($)
N/A
Valuation ($)
5.5 b
Valuation ($)
1.3 b
Valuation ($)
76.8 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1.7 k
Twitter followers
1.4 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.6
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
197124
Alexa Website Rank
N/A
Alexa Website Rank
304877
Alexa Website Rank
645582
Alexa Website Rank
186566
Employee Rating
Employee Rating
3.5
Employee Rating
3.5
Employee Rating
3
Employee Rating
2.8
Employee Rating
4.1

Financial

Revenue (est.)
Revenue (est.)
$29.6m (FY, 2019)
Revenue (est.)
$173.8m (FY, 2018)
Revenue (est.)
$182.2m (FY, 2019)
Revenue (est.)
£456.9m (FY, 2019)
Revenue (est.)
$99.2m (FY, 2019)
Cost of goods
Cost of goods
$4.1m (FY, 2019)
Cost of goods
$59.4m (FY, 2018)
Cost of goods
$22m (FY, 2019)
Cost of goods
£274.6m (FY, 2019)
Cost of goods
$51m (FY, 2019)
Gross profit
Gross profit
$25.4m (FY, 2019)
Gross profit
$114.4m (FY, 2018)
Gross profit
$160.3m (FY, 2019)
Gross profit
£182.3m (FY, 2019)
Gross profit
$48.2m (FY, 2019)
Net income
Net income
($20.6m) (FY, 2019)
Net income
($147.7m) (FY, 2018)
Net income
($356.4m) (FY, 2019)
Net income
£5.2m (FY, 2019)
Net income
($18.6m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 20m
Total funding raised
N/A
Total funding raised
$ 88m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Array BioPharma
HQ
Boulder, US

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

View company
Amicus Therapeutics
HQ
Cranbury Township, US
Employees
584↑ 15% increase

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

View company
Clinigen Group
HQ
Burton upon Trent, GB
Employees
1,133↑ 42% increase

A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time

View company
Recro Gainesville
HQ
Malvern, US
Employees
213↓ 16% decrease

Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.

View company